← Back to Search

Gut Bacteria Analysis for Type 2 Diabetes (DBBIOTE Trial)

N/A
Recruiting
Led By André Marette, PhD
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights
No Placebo-Only Group

Summary

This trial will explore the effects of different types of gut bacteria on obese individuals with type 2 diabetes.

Who is the study for?
This trial is for individuals who have been newly diagnosed with type 2 diabetes or those without the disease. Participants should not be taking any oral medications for lowering blood sugar, cholesterol, or blood pressure.
What is being tested?
The study involves an endoscopy and duodenal biopsy to explore how gut bacteria might influence type 2 diabetes by affecting insulin resistance and glucose tolerance.
What are the potential side effects?
Potential side effects include discomfort from the endoscopy procedure, such as sore throat, bloating, nausea, and risks associated with biopsies like bleeding or infection.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
This trial's timeline: 3 weeks for screening, Varies for treatment, and one week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Microbial signature

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Type 2 Diabetes patientsExperimental Treatment1 Intervention
Upper gut biopsies and lower gut samples
Group II: Non Type 2 Diabetes patientsActive Control1 Intervention
Upper gut biopsies and lower gut samples

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
434 Previous Clinical Trials
178,598 Total Patients Enrolled
André Marette, PhDPrincipal InvestigatorLaval University
2 Previous Clinical Trials
90 Total Patients Enrolled

Media Library

Endoscopy and duodenal biopsy and sampling Clinical Trial Eligibility Overview. Trial Name: NCT04579900 — N/A
Type 2 Diabetes Research Study Groups: Non Type 2 Diabetes patients, Type 2 Diabetes patients
Type 2 Diabetes Clinical Trial 2023: Endoscopy and duodenal biopsy and sampling Highlights & Side Effects. Trial Name: NCT04579900 — N/A
Endoscopy and duodenal biopsy and sampling 2023 Treatment Timeline for Medical Study. Trial Name: NCT04579900 — N/A
~8 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top